featured
ASCO: Final Overall Survival Results for Olaparib Maintenance in BRCA-Mutated Ovarian Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles: